Benzimidazole compounds as HDAC6 inhibitors
Abstract:
Novel compounds of Formula I are described, where the compounds are selective HDAC6 inhibitors suitable for treatment of diseases associated with HDAC6, where X, Y, Z, A1, A2, Q1 and Q2 are as described.
Information query
Patent Agency Ranking
0/0